Quanterix Corporation (QTRX) Investor Relations Documents

Quanterix Corporation (QTRX) investor relations documents from the company's IR site: 12 presentations, 28 press releases; latest deck 2026-08-10. Read in-app with summaries. First-party data.

Quanterix Corporation Q2 2026 Earnings Call — Quanterix Q2 2026 earnings report shows $32.9M revenue, $85M in realized cost synergies, and a revised full-year 2026 revenue guidance of $142M to $148M.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-10Press releaseQuanterix Releases Financial Results for the Second Quarter of 2026
2026-08-10Press releaseQuanterix Names Jim Gute Chief Commercial Officer
2026-08-10Earnings deckQuanterix Corporation Q2 2026 Earnings Call
2026-08-06Press releaseQuanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12
2026-08-04Press releaseQuanterix To Report Second Quarter 2026 Financial Results on August 10, 2026
2026-07-16Press releaseQuanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-07-14Press releaseAnthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data
2026-06-16Press releaseQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-09Press releaseQuanterix Announces Appointment of Jason Faessler as Chief Financial Officer
2026-06-04Press releaseQuanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
2026-06-03Press releaseQuanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
2026-05-06Press releaseLucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clini
2026-04-17Press releaseAidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology
2026-04-15Press releaseQuanterix Debuts Content Innovation Engine at AACR 2026
2026-03-02Press releaseLucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
2026-02-26Press releaseQuanterix to Participate in Upcoming Investor Conferences
2026-02-03Press releaseQuanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer’s Disease Detection
2026-01-21Press releaseQuanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer
2025-05-12Earnings deckQuanterix Corporation Q1 2025 Earnings Call
2025-04-28PresentationQuanterix Amends Agreement with Akoya
2025-03-17Earnings deckQuanterix Corporation Q4 2024 Earnings Call
2025-03-17Press releaseQuanterix Releases Financial Results for the Fourth Quarter of 2024
2025-01-15PresentationQuanterix 2025 J.P. Morgan Presentation
2024-11-12Press releaseQuanterix Releases Preliminary Financial Results for the Third Quarter of 2024
2024-08-08Press releaseQuanterix Releases Financial Results for the Second Quarter of 2024
2024-05-07Press releaseQuanterix Releases Financial Results for the First Quarter of 2024
2024-02-29Earnings deckQuanterix Corporation Q4 2023 Earnings Call
2024-02-29Press releaseQuanterix Releases Operating Results for Fourth Quarter and Full Year 2023
2023-11-07Earnings deckQuanterix Corporation Q3 2023 Earnings Call
2023-11-06Press releaseQuanterix Releases Operating Results for Third Quarter 2023
2023-08-08Earnings deckQuanterix Corporation Q2 2023 Earnings Call
2023-08-07Press releaseQuanterix Releases Operating Results for Second Quarter 2023
2023-05-09Earnings deckQuanterix Corporation Q1 2023 Earnings Call
2023-05-09Press releaseQuanterix Releases Operating Results for First Quarter 2023
2023-03-06Earnings deckQuanterix Corporation Q4 2022 Earnings Call
2023-03-06Press releaseQuanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations
2022-11-08Earnings deckQuanterix Corporation Q3 2022 Earnings Call
2022-11-08Press releaseQuanterix Corporation Releases Operating Results for Third Quarter 2022
2022-08-08Press releaseQuanterix Corporation Releases Operating Results for Second Quarter 2022, Announces Business Re-Alignment Plan and Revis
2022-05-10Earnings deckQuanterix Corporation Q1 2022 Earnings Call

QTRX overview · QTRX earnings · QTRX financials · QTRX KPIs · QTRX ownership · QTRX peers · QTRX filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.